Tourists walk next to Victoria Harbour in the Tsim Sha Tsui district as Two International Finance Centre (IFC), center, and other commercial buildings stand in the background on Hong Kong island in Hong Kong, China, on Tuesday, Oct. 21, 2014.  (BRENT LEWIN / BLOOMBERG)

Hong Kong’s bankers are working around the clock as the region’s companies rush to go public.

Initial public offerings in the city have already hit almost US$11 billion, a close to 500 percent jump from a year earlier, with video streaming platform Bilibili Inc and search giant Baidu Inc among companies preparing multi-billion dollar deals. Digital roadshows and clients eager to move faster to capture abundant liquidity - especially as market sentiment has begun to sour - means bankers are keeping dawn-to-midnight schedules, say some, even turning down deals where they’re relegated to junior roles.

ALSO READ: Global IPO market eyes record 1st quarter even as SPACs falter

Digital roadshows and clients eager to move faster to capture abundant liquidity - especially as market sentiment has begun to sour - means bankers are keeping dawn-to-midnight schedules, say some, even turning down deals where they’re relegated to junior roles

Companies are trying to “get the deal done as soon as they can,” said Stephanie Tang, head of private equity for greater China at Hogan Lovells. “Many of them see this as an opportunity and if they are not catching the train quickly, they might lose the opportunity.”

A pandemic-induced hunger for technology stocks and the threat of US delistings have been a boon for the financial hub during a difficult political stretch, driving a surge in initial and secondary share sales.

Unsurprisingly, the health sector is the busiest, with deals poised for both Hong Kong and the US Goldman Sachs Group Inc’s healthcare team is working on at least 20 IPOs in the US$300 million to US$1 billion range. Citigroup Inc has won eight Chinese mainland healthcare mandates in the three weeks just before Lunar New Year, expecting to raise US$300 million to US$400 million for each in July through September. Citi has also nabbed the WeDoctor IPO, which is seeking to raise as much as US$3 billion at a pre-IPO valuation of US$12 billion. The details were shared by bankers and executives familiar with the deals, who asked not to be named discussing private matters.

Representatives for Goldman Sachs and Citi declined to comment on the deals. WeDoctor also declined to comment.

 “It’s busier than ever,” said Udhay Furtado, Citi’s co-head of Asia Equity Capital Markets. “This is an attractive window for issuers and liquidity is available across financing products.”

But the bustle comes loaded with execution risk as the Chinese mainland markets in early February started to stumble after a two-year rally and what’s looking like the biggest-ever quarter for initial public offerings fueled by a US-led boom in blank-check listings.

READ MORE: Hong Kong considering allowing SPAC listings

In one recent deal, Autohome Inc, a Chinese mainland online car-sales website, sold shares in the city at about a 5.5 percent discount to its last price in New York. Given the current volatility in the markets, only the most straightforward deals are also being pushed ahead right now, according to a banker in Hong Kong.

Rushing out

Many companies pushing to sell shares have yet to establish a sustainable way to make profits, including Chinese grocery delivery apps such as Meicai and Dingdong Maicai, who are facing heavy cash burn to win market share.

The health sector is the busiest, with deals poised for both Hong Kong and the US Goldman Sachs Group Inc’s healthcare team is working on at least 20 IPOs in the US$300 million to US$1 billion range

Liao Ming, the founder of Prospect Avenue Capital, which oversees US$500 million in private equity assets, said he expects at least five of his portfolio companies to list this year, out of a total 12.

“A lot of these companies including the grocery space, wouldn’t be able to find investors in a normal year,” said the Beijing-based former Morgan Stanley banker. “But because of the bullish sentiment this year, a lot of companies that aren’t ready yet are rushing to get out the door.”

Charles Chau, Hong Kong-based partner at law firm Jones Day, said most clients are trying to submit IPO applications by March and supply additional financial statements by June to get a listing done by September.

The rush back home by Chinese mainland stalwarts has been going since last year, when firms such as Netease Inc and JD.com Inc listed in Hong Kong.

Last year, Hong Kong saw US$52 billion in listings, just below the US$58 billion that was raised in 2010, according to data compiled by Bloomberg.

Accelerated plans

The migration to virtual roadshows means bankers are able to pack more meetings into their schedules. “IPO professional intermediaries have transformed themselves,” said Edward Au, southern region managing partner at Deloitte China.

In the US, markets have boomed with the listings of SPACs, or special purpose acquisition companies. That’s also now reshaping Asian banking. JPMorgan Chase & Co and Credit Suisse Group AG have pulled people from corporate finance and equity capital markets to focus on those types of deals in Asia, according to people with knowledge of the moves.

Credit Suisse declined to comment.

Francesco Lavatelli, head of equity capital markets for Asia Pacific at JPMorgan, said the US bank has a “healthy pipeline” of deals, including SPAC IPOs and mandates from companies looking to combine with an already listed SPAC, known as a deSPAC.

He said the recent stock turmoil is unlikely to derail the deals on tap. “If anything, it will accelerate plans, which might mean in some cases a deSPAC process,” the Hong Kong-based banker said.